Using data from TCGA melanoma dataset via cBioportal, which contains expression data from 458 patients of various stages of melanoma, the researchers found that high collagen expression is associated with poorer patient survival, especially when there is also expression of MITF target genes including TRPM1, TYP, TYRP1 (differentiation markers) [25]. This evidence concerns the gene TYRP1 and melanoma.